American Research & Management Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
American Research & Management Company's EW Position: Q3 2022 in Review
American Research & Management Company increased its Edwards Lifesciences (EW) stake by 5.5% in Q3 2022, buying an estimated $153K and bringing the position to 30,520 shares worth $2.52M. The position accounts for 0.7% of the portfolio, ranked #42.
American Research & Management Company first reported a position in EW in Q2 2016 and has held it in 16 quarters since. The position peaked at $3.58M in Q4 2021. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.
- American Research & Management Company held 30,520 shares of Edwards Lifesciences worth $2.52M as of Q3 2022.
- American Research & Management Company bought 1,594 Edwards Lifesciences shares in Q3 2022, an estimated $153K.
- Edwards Lifesciences made up 0.7% of American Research & Management Company's portfolio in Q3 2022, its #42 holding.
- American Research & Management Company first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 16 quarters since.
- American Research & Management Company's Edwards Lifesciences position peaked at $3.58M in Q4 2021.
- 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.